18 May 2013
Keywords: Lung and gastric cancer, Research, Asia, Eli Lilly, Merck & Co, Pfizer, ACRG
Article | 23 February 2010
With the aim of accelerating research and improve treatment for lung and gastric cancer in Asia, three US drug giants ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 February 2010
24 February 2010
25 February 2010
17 May 2013
© 2013 thepharmaletter.com